<?xml version="1.0" encoding="UTF-8"?>
<p>Regarding stem cell therapies in the treatment of HF, few studies have been conducted in Iran. Mohyeddin-Bonab et al. conducted one study in Iran with the title of “Autologous in Vitro Expanded Mesenchymal Stem Cell Therapy for Human Old Myocardial Infarction” on 8 patients in a study group and 8 patients in a control group. The results of this study showed Left Ventricular Ejection Fraction increased significantly in the test group (P= 0.005), but not in the control group. In comparison, between the test and control groups, the results of NYHA assessment demonstrated significant improvement in the test group. The reason for the difference between the results of their study and ours is the type of patients studied. In Mohyeddin-Bonab et al.’s study, all 8 patients had an old myocardial infarction. However, in our study, patients with heart failure had different conditions [
 <xref rid="R12" ref-type="bibr">12</xref>].
</p>
